tiprankstipranks
Phathom Pharmaceuticals (PHAT)
NASDAQ:PHAT
US Market
Holding PHAT?
Track your performance easily

Phathom Pharmaceuticals (PHAT) Technical Analysis

313 Followers

Technical Sentiment

Overall Consensus
Sell
5Bullish
2Neutral
15Bearish
Technical Analysis Consensus
Buy
5Bullish
2Neutral
3Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Phathom Pharmaceuticals’s (PHAT) Moving Averages Convergence Divergence (MACD) indicator is -1.37, suggesting Phathom Pharmaceuticals is a Sell.
Phathom Pharmaceuticals’s (PHAT) 20-Day exponential moving average is 9.54, while Phathom Pharmaceuticals’s (PHAT) share price is $8.14, making it a Sell.
Phathom Pharmaceuticals’s (PHAT) 50-Day exponential moving average is 11.85, while Phathom Pharmaceuticals’s (PHAT) share price is $8.14, making it a Sell.

Phathom Pharmaceuticals (PHAT) Pivot Points

Dec 21, 2024, 06:39 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
7.23
7.57
7.78
8.12
8.33
8.67
8.88
Fibonacci
7.57
7.78
7.91
8.12
8.33
8.46
8.67
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Phathom Pharmaceuticals (PHAT) Moving Averages

Dec 21, 2024, 06:39 AM
Period
Simple
Exponential
MA5
8.50Sell
8.31Sell
MA10
8.65Sell
8.63Sell
MA20
8.85Sell
9.54Sell
MA50
13.07Sell
11.85Sell
MA100
14.09Sell
12.73Sell
MA200
12.18Sell
11.61Sell
Phathom Pharmaceuticals’s (PHAT) 10-Day exponential moving average is 8.63, while Phathom Pharmaceuticals’s (PHAT) share price is $8.14, making it a Sell.
Phathom Pharmaceuticals’s (PHAT) 100-Day exponential moving average is 12.73, while Phathom Pharmaceuticals’s (PHAT) share price is $8.14, making it a Sell.
Phathom Pharmaceuticals’s (PHAT) stock price is $8.14 and Phathom Pharmaceuticals’s (PHAT) 50-day simple moving average is 13.07, creating a Sell signal.
Phathom Pharmaceuticals’s (PHAT) stock price is $8.14 and Phathom Pharmaceuticals’s (PHAT) 100-day simple moving average is 14.09, creating a Sell signal.
Phathom Pharmaceuticals’s (PHAT) stock price is $8.14 and Phathom Pharmaceuticals’s (PHAT) 200-day simple moving average is 12.18, creating a Sell signal.

Phathom Pharmaceuticals (PHAT) Technical Indicators

Dec 21, 2024, 06:39 AM
Name
Value
Implied Action
RSI (14)
29.53
Buy
STOCH (9,6)
18.66
Buy
STOCHRSI (14)
17.36
Buy
MACD (12,26)
-1.37
Sell
ADX (14)
36.25
Neutral
Williams %R
-90.91
Buy
CCI (14)
-228.64
Buy
ATR (14)
0.89
-
Ultimate Oscillator
37.07
Neutral
ROC
-15.52
Sell
Phathom Pharmaceuticals’s (PHAT) Relative Strength Index (RSI) is 29.53, creating a Buy signal.
Phathom Pharmaceuticals’s (PHAT) Trend Strength Indicator (ADX) is 36.25, creating a Neutral signal.
Phathom Pharmaceuticals’s (PHAT) Commodity Channel Index (CCI) is -228.64, creating a Buy signal.
Phathom Pharmaceuticals’s (PHAT) Price Rate of Change (ROC) is -15.52, creating a Sell signal.

FAQ

Is PHAT a Buy, Hold, or Sell?
Based on PHAT’s technical indicators, PHAT is a Sell.
    What is PHAT’s RSI (14)?
    PHAT’s RSI (14) is 29.53, which suggests PHAT is a Buy.
      What is PHAT’s MACD?
      PHAT’s MACD is -1.37, which suggests PHAT is a Sell.
        What is PHAT’s 5-day moving average?
        PHAT’s 5-day moving average is 8.50, which suggests PHAT is a Sell.
          What is PHAT’s 20-day moving average?
          PHAT 20-day moving average is 8.85, which suggests PHAT is a Sell.
            What is PHAT’s 50-day moving average?
            PHAT’s 50-day moving average is 13.07, which suggests PHAT is a Sell.
              What is PHAT’s 200-day moving average?
              PHAT’s 200-day moving average is 12.18, which suggests PHAT is a Sell.
                What is PHAT’s Williams % R (14)?
                PHAT’s Williams % R (14) is -90.91, which suggests PHAT is a Buy.
                  What is PHAT’s CCI (14)?
                  PHAT’s CCI (14) is -228.64, which suggests PHAT is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis